PPT Slide

Levofloxacin and moxifloxacin in CAP

PRO’S

Anti-bacterial activity and clinical efficiency

• Bio-equivalency po - iv

• Quick sequential therapy

• OD - BID

• High tissue disposition

Pharmacokinetic advantages

• Respiratory bacteria and atypicals

• Not related to peni- and macrolide-resistance

Previous slide

Next slide

Back to first slide

View graphic version